Differences in information seeking among breast, prostate, and colorectal cancer patients: Results from a population-based survey

Rebekah H. Nagler(University of Minnesota), Robert Hornik(University of Pennsylvania), Stacy W. Gray(City of Hope), Bridget Kelly(RTI International), J. Sanford Schwartz(Cincinnati Children's Hospital Medical Center), Anca Romantan(University of Massachusetts Amherst), Katrina Armstrong(Columbia University), Angela DeMichele(University of Pennsylvania)
Patient Education and Counseling
October 10, 2010
10.1016/j.pec.2010.09.010
Cited by 193

Related Papers

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
|The Lancet Oncology|2016|1.8k
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
|New England Journal of Medicine|2018|1.3k
Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults
|JAMA Pediatrics|2017|1.2k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707